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CASE REPORTSManagement of endograft infection coupled with aortoesophageal
fistula: Extra-anatomic aortic bypass and endograft explantationMariangela De Masi, MD, Philippe Amabile, MD, Laurence Bal, MD, and Philippe Piquet, MD,
Marseille, FranceThoracic endovascular aortic repair (TEVAR) is an accepted
method of treating thoracic aortic aneurysms located on
the descending thoracic aorta.1 Herein, we describe a case
of a secondary aortoesophageal fistula (AEF), and its
management.CLINICAL SUMMARY
A man, aged 44 years, a tobacco user, was referred with
thoracic back pain. The patient had a history of back pain
for 7 months that had become unrelenting for the past 2
weeks. His blood test results revealed the following: hemo-
globin, 100 g/L; leucocyte, 13.67 3 109/L; and C-reactive
protein, 181 mg/L.
The computed tomographic angiography (CTA) revealed
a bulky aneurysm (diameter, 65 mm) of the descending
thoracic aorta (Figure 1, A).
EmergencyTEVARwas performed using a 263 134-mm
Zenith endograft (Cook, Inc, Bloomington, Ind). The
procedure was technically successful, and the patient was
discharged from the hospital.
He was seen again 9 days later with back pain, asthenia,
and sporadic bouts of slight fever; his blood test results
revealed elevated inflammatory markers.
The CTA showed the presence of air bubbles in the
excluded aneurysmal sac (Figure 1, B). An AEF was diag-
nosed. A gastrostomy was performed for enteral feeding,
and intravenous antibiotics, piperacillin/tazobactam, were
started. One week later, there was a clear improvement in
pain and in the inflammatory syndrome. A CTA performed
1 month later showed an aortic aneurysm developing
around the distal part of the endograft (Figure 1, C). Esoph-
agogastroduodenoscopy was immediately followed by
massive hematemesis. A second endograft was placed on
the level of the developing aneurysm and successfully
stopped the bleeding.
The persistence of the AEF and its complication, despite
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ioned between the ascending and the supraceliac aorta
(‘‘ventral aorta’’). A 16-mm Dacron graft was anastomosed
end to side to the supraceliac aorta and tunneled into the
mediastinum through the diaphragm. The graft was carried
along the lateral border of the right atrium, and anasto-
mosed proximally to the right lateral aspect of the ascending
aorta.
The second surgical stagewas performed during the same
procedure. The patient was placed in a lateral decubitus
position. An anterolateral thoracotomy was performed,
entering through the fifth intercostal space. After clamping,
the aorta was opened longitudinally, and the 2 endografts
were removed. The proximal and distal ends of the thoracic
aorta were ligated with 4-0 polypropylene running sutures.
The esophageal fistula was identified, debrided, and
repaired with a simple suture. The chest and mediastinum
were copiously irrigated and drained. Results of intraoper-
ative cultures of the aortic wall were negative.
The patient had an uncomplicated postoperative recov-
ery: a regular diet was resumed 2 weeks later, without swal-
lowing difficulties, and the antibiotics were maintained for
10 days.
Three years after explantation of the endograft, the
patient continues to do well (Figure 1, D).DISCUSSION
Secondary AEF after TEVAR has been reported, with an
incidence of 1.9%,2 and can have disastrous outcomes.
Several pathophysiologic mechanisms have been suggested
for secondary AEF after TEVAR. The hypotheses include
the following: (1) erosion of the relatively rigid stent-graft
through the aorta directly into the esophagus, (2) necrosis
of the esophageal wall because of continuous pressure of
the self-expanding endoprosthesis, (3) ischemic esophageal
necrosis because of stent-graft coverage of aortic side
branches that feed the esophagus, and (4) infection of the
stent-graft that eventually extends to the esophagus, eroding
its wall.2
For our patient, potential ischemic necrosis of the esoph-
ageal wall because of coverage of the aortic side branches
that feed the esophagus could be discussed. Endovascular
thoracic aorta stenting for AEF might be useful as a
temporary measure before definitive open surgery. How-
ever, it should only be considered as a stopgap measure to
achieve short-term hemostasis until definitive treatmentrdiovascular Surgery c Volume 146, Number 3 e11
FIGURE 1. Vascular computed tomographic (CT) scan with axial native images (upper row), curved multiplanar reconstruction (middle row), and volume-
rendering reconstruction (lower row) acquired before any treatment (A), after the first and second endovascular procedures (B and C, respectively), and after
surgical treatment (D). In A, a CT scan showed a huge aneurysm that compressed the esophagus and left atrium. In B, the CT scan showed air bubbles (large
arrows) in the excluded aneurismal sac, esophageal lumen (thin arrow), and aortoesophageal fistula (open arrow). In C, an aortic aneurysm developed
around the distal part of endograft (thin arrow). In D, the image shows 3 years after thoracic endograft explantation (thin arrow) and ventral aortic bypass
(large arrow).
Case Reportsby conventional surgery within a few hours or days.3 This
was the management method that we opted for.
Aortic graft replacement and esophageal fistula repair
are the only definitive treatment for AEF. Aortic recon-
struction can be performed in situ using synthetic grafts,
cryopreserved arterial allografts,4 or an extra-anatomic
bypass. We choose an extra-anatomic bypass arising
from the ascending aorta (ventral aorta) to reduce the
risk5 by routing the graft away from the infected areas.e12 The Journal of Thoracic and Cardiovascular SurgTreatment of the esophageal defect is mandatory.
Direct suture is feasible only for small lesions that are
detected early, with no significant mediastinitis, as in
our case.
CONCLUSIONS
The treatment of secondary AEF after TEVAR can be
achieved efficiently and durably by debridement and an
extra-anatomic bypass. TEVAR remains a stopgap measure,ery c September 2013
Case Reportsalthough it is the best therapeutic strategy in an acute
setting.
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tion. J Vasc Surg. 2010;51:207-9.Uterine leiomyoma extension into right atrium: A case reportHua-shan Xu, MD,a Khan Mohammed Firoj, MM,a Kamran Yunus Inamdar, MM,b and
Wen-zeng Zhao, MM,a Zhengzhou and Urumchi, ChinaUterine leiomyoma is a common disease in women; how-
ever, intravenous leiomyomatosis of uterine origin extend-
ing via inferior vena cava (IVC) into the right side of the
heart, known as intracardiac leiomyomatosis (ICL), is a
rare condition. Because of rarity, ICL is occasionally
misdiagnosed as a right atrial myxoma and thrombus.
CASE REPORT
A 42-year-old married premenopausal woman complain-
ing of intermittent vaginal bleeding was referred to our
department for an intracardiac mass. She had a 1-month his-
tory of progressive breathlessness, fatigue on exercise, and
edema of her lower extremities. Her echocardiogram re-
vealed a large mass in the right atrium, and the mass
extended via the IVC far into the pelvic vein (Figure 1),
which was confirmed on magnetic resonance imaging
(Figure 2). Because of unfamiliarity to the disease, it was
diagnosed as right atrial myxoma, combined with long-
standing IVC thrombosis. Later, pelvic ultrasonography re-
vealed multiple leiomyomas of the uterus, which made the
attention toward the diagnosis of ICL.
The patient underwent a 2-stage surgery. In the first
stage (transatrial tumor resection), the operation was per-
formed under normal temperature with establishment ofcardiopulmonary bypass (CPB) by draining the blood
from a single superior vena cava and recirculating back
through the aortic root. The tumor mass was having a
tailed-like structure invaded into the IVC (Figure 3), which
was pulled out gently through the right atrial incision. Imme-
diately after pulling out the mass, the IVC cannula was
advanced into the IVC. The surgical views revealed that
the tumor within the vessel and heart had no stalk and had
well-demarcated borders with the wall of vessel and heart
(Figure 3). Subsequently, the pathological report also
confirmed uterine smooth muscle origin. So, oral tamoxifen
(10 mg/d, twice a day for 3 months) was administered. The
second-stage surgery (hysterectomy)was done 2weeks later
for removing multiple uterine leiomyomas. In the recent
3 years of follow-up, she had no symptoms.DISCUSSION
ICL is exceedingly rare. Most patients are usually pre-
menopausal (median age, 44 years). A review of the litera-
ture reveals that more than half of the women with ICL hadFIGURE 1. Apical 4-chamber view of echocardiography with a right
atrialmass.RV, Right ventricle; LV, left ventricle;RA, right atrium;M, mass.
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